Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Indaptus Therapeutics
INDP
$136M
| $313K | ﹤0.01% |
493
+369
| +298% | +$228K |
|
|
SUMR
3027
DELISTED
Summer Infant, Inc.
SUMR
| $313K | ﹤0.01% |
38,999
-1,524
| -4% | -$6.79K |
|
3028
Live Ventures
LIVE
$33.5M
| $312K | ﹤0.01% |
32,799
+4,736
| +17% | +$37.1K |
|
|
MOGU
3029
MOGU Inc
MOGU
$15.3M
| $311K | ﹤0.01% |
14,375
+10,783
| +300% | +$165K |
|
3030
Movado Group
MOV
$815M
| $310K | ﹤0.01% |
+28,598
| New | +$309K |
|
|
RNDB
3031
DELISTED
Randolph Bancorp, Inc. Common Stock
RNDB
| $310K | ﹤0.01% |
30,892
+9,692
| +46% | +$91.7K |
|
|
CBAY
3032
DELISTED
Cymabay Therapeutics
CBAY
| $309K | ﹤0.01% |
+88,520
| New | +$255K |
|
|
AXIA
3033
DELISTED
AXIA Energia
AXIA
| $306K | ﹤0.01% |
68,193
-1,151,961
| -94% | -$4.5M |
|
|
SDEV
3034
Stablecoin Development Corp
SDEV
$50.6M
| $306K | ﹤0.01% |
43
+31
| +258% | +$174K |
|
3035
Wolverine World Wide
WWW
$1.48B
| $305K | ﹤0.01% |
12,800
-312,500
| -96% | -$6.35M |
|
3036
Gray Media Inc
GTN.A
$612M
| $304K | ﹤0.01% |
23,400
-400
| -2% | -$5.17K |
|
3037
First Internet Bancorp
INBK
$255M
| $304K | ﹤0.01% |
18,301
-62,700
| -77% | -$983K |
|
3038
Aemetis
AMTX
$126M
| $303K | ﹤0.01% |
+374,807
| New | +$272K |
|
3039
S&T Bancorp
STBA
$1.82B
| $303K | ﹤0.01% |
12,936
-21,564
| -63% | -$522K |
|
3040
AGM Group Holdings
AGMH
$2.37M
| $302K | ﹤0.01% |
+232
| New | +$234K |
|
3041
Optical Cable Corp
OCC
$149M
| $301K | ﹤0.01% |
120,303
+4,900
| +4% | +$12.4K |
|
|
IHC
3042
DELISTED
Independence Holding Company
IHC
| $300K | ﹤0.01% |
+9,800
| New | +$274K |
|
3043
vTv Therapeutics
VTVT
$125M
| $299K | ﹤0.01% |
3,319
-4,063
| -55% | -$401K |
|
3044
Invesco CEF Income Composite ETF
PCEF
$823M
| $298K | ﹤0.01% |
+15,000
| New | +$286K |
|
|
AGPU
3045
Axe Compute Inc
AGPU
$92.4M
| $298K | ﹤0.01% |
+606
| New | +$283K |
|
|
CBMB
3046
DELISTED
CBM Bancorp, Inc.
CBMB
| $296K | ﹤0.01% |
24,105
+4,802
| +25% | +$57.4K |
|
3047
Equillium
EQ
$138M
| $295K | ﹤0.01% |
100,149
+39,702
| +66% | +$113K |
|
3048
Gevo
GEVO
$391M
| $295K | ﹤0.01% |
372,124
-204,409
| -35% | -$222K |
|
3049
Riot Platforms
RIOT
$7.21B
| $295K | ﹤0.01% |
132,952
-200,949
| -60% | -$359K |
|
|
SANW
3050
DELISTED
S&W Seed Co
SANW
| $294K | ﹤0.01% |
6,789
+4,132
| +156% | +$163K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.